Polymorphisms in Slc26a9 are associated with an increased incidence and poor prognosis of diabetic individuals with CF (Blackman et al., 2013), However, knowledge of the expression and function of Slc26a9 in the pancreas and biliary system is lacking. The gene discussed is SLC26A9; the disease is cystic fibrosis.